STAGEN CO LTD has a total of 23 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2004. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, computer technology and biotechnology are JAZZ PHARMACEUTICALS INC, SIFI SPA and MERITAGE PHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | China | 3 | |
#5 | Canada | 2 | |
#6 | Hong Kong | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Mexico | 1 | |
#9 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Computer technology | |
#3 | Biotechnology | |
#4 | IT methods for management | |
#5 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Kamatani Naoyuki | 21 |
#2 | Nishino Takeshi | 8 |
#3 | Taniguchi Atsuo | 4 |
#4 | Kamatani Youichirou | 3 |
#5 | Naoyuki Kamatani | 2 |
#6 | Atsuo Taniguchi | 1 |
#7 | Ito Toshikazu | 1 |
#8 | Takeshi Nishino | 1 |
#9 | Kitamura Yutaka | 1 |
Publication | Filing date | Title |
---|---|---|
WO2018092911A1 | Intracellular atp enhancer | |
WO2017033963A1 | Agent for enhancing atp in cells |